1. Home
  2. ARI vs COLL Comparison

ARI vs COLL Comparison

Compare ARI & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARI
  • COLL
  • Stock Information
  • Founded
  • ARI 2009
  • COLL 2002
  • Country
  • ARI United States
  • COLL United States
  • Employees
  • ARI N/A
  • COLL N/A
  • Industry
  • ARI Real Estate Investment Trusts
  • COLL Biotechnology: Pharmaceutical Preparations
  • Sector
  • ARI Real Estate
  • COLL Health Care
  • Exchange
  • ARI Nasdaq
  • COLL Nasdaq
  • Market Cap
  • ARI 1.1B
  • COLL 947.6M
  • IPO Year
  • ARI 2009
  • COLL 2015
  • Fundamental
  • Price
  • ARI $9.86
  • COLL $29.90
  • Analyst Decision
  • ARI Hold
  • COLL Strong Buy
  • Analyst Count
  • ARI 5
  • COLL 4
  • Target Price
  • ARI $9.83
  • COLL $43.75
  • AVG Volume (30 Days)
  • ARI 1.3M
  • COLL 279.3K
  • Earning Date
  • ARI 08-05-2025
  • COLL 08-07-2025
  • Dividend Yield
  • ARI 10.15%
  • COLL N/A
  • EPS Growth
  • ARI N/A
  • COLL N/A
  • EPS
  • ARI N/A
  • COLL 1.25
  • Revenue
  • ARI $276,844,000.00
  • COLL $664,283,000.00
  • Revenue This Year
  • ARI $32.11
  • COLL $20.04
  • Revenue Next Year
  • ARI $19.41
  • COLL $3.98
  • P/E Ratio
  • ARI N/A
  • COLL $23.82
  • Revenue Growth
  • ARI 104.64
  • COLL 17.17
  • 52 Week Low
  • ARI $7.70
  • COLL $23.23
  • 52 Week High
  • ARI $11.20
  • COLL $42.29
  • Technical
  • Relative Strength Index (RSI)
  • ARI 53.39
  • COLL 55.25
  • Support Level
  • ARI $9.72
  • COLL $29.11
  • Resistance Level
  • ARI $9.97
  • COLL $30.30
  • Average True Range (ATR)
  • ARI 0.15
  • COLL 0.71
  • MACD
  • ARI -0.03
  • COLL -0.03
  • Stochastic Oscillator
  • ARI 41.49
  • COLL 44.32

About ARI Apollo Commercial Real Estate Finance Inc

Apollo Commercial Real Estate Finance Inc is a real estate investment trust that primarily originates, invests in, acquires, and manages commercial first-mortgage loans, subordinate financings, commercial mortgage-backed securities, and other real estate-related debt investments. The subordinate loans and first-mortgage loans account for the vast majority of the portfolio on a cost basis. Property types include residential, retail, healthcare, office, mixed-use, hotel, industrial, multifamily, securities, and other, with residential properties and hotels representing the highest property value. More than a third of the properties are located in New York City, with the other properties located across other regions of the United States, as well as other countries.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Share on Social Networks: